Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B

類似資料

• Predicting response to peginterferon α‐2a, lamivudine and the two combined for HBeAg‐negative chronic hepatitis B
  著者:: Bonino, F, 等
  出版事項: (2007)
• HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patients
  著者:: Yang, Song, 等
  出版事項: (2016)
• No association between IFNL3 (IL28B) genotype and response to peginterferon alfa-2a in HBeAg-positive or -negative chronic hepatitis B
  著者:: Wei, Lai, 等
  出版事項: (2018)
• Predictors for early HBeAg loss during lamivudine therapy in HBeAg-positive chronic hepatitis B patients with acute exacerbation
  著者:: Peng, Cheng-Yuan, 等
  出版事項: (2010)
• Relapse after treatment with peginterferon α‐2b alone or in combination with lamivudine in HBeAg positive chronic hepatitis B
  著者:: Flink, H J, 等
  出版事項: (2007)